November 2016
Oncology
Peer Reviewed | Web-Exclusive

CBC Quiz: The Chemotherapy Patient

CBC abnormalities can have a significant impact on treatment options for a chemotherapy patient. This quiz presents different scenarios with accompanying CBC changes that can commonly occur in patients treated with the CHOP B-cell lymphoma protocol and offers solutions on how to adapt each treatment plan accordingly.

Bear, a 7-year-old castrated golden retriever with B-cell lymphoma, is currently undergoing a CHOP-L (cyclophosphamide, hydroxyl doxorubicin, vincristine [Oncovin], prednisone, L-asparaginase) chemotherapy protocol; see Table 11 for interpretation of the neutrophil counts cited in the following scenarios.


Sign in to continue reading this article

Not registered? Create an account for free to read full articles on www.cliniciansbrief.com.

To access full articles on www.cliniciansbrief.com, please sign in below.

Busy? Sign in Faster. Sign into www.cliniciansbrief.com with your social media account.
Up Next